Clinical Trials in Atlanta

Showing 4141-4160 of 19,805 trials

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

NCT05367960

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).

Fragile X Syndrome

Tetra Discovery Partners314 participantsStarted Nov 2022

Irvine, California, United States • Orange, California, United States • Sacramento, California, United States +14 more locations

Active Not Recruiting< 1 mile

Biobank For MS And Other Demyelinating Diseases

NCT00445367

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Multiple SclerosisTransverse MyelitisNeuromyelitis Optica+2 more

Accelerated Cure Project for Multiple Sclerosis3,226 participantsStarted May 2006

Phoenix, Arizona, United States • Stanford, California, United States • Aurora, Colorado, United States +7 more locations

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Biobank For MS And Other Demyelinating Diseases

Find Trials by Condition in Atlanta

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Improving Outcomes Assessment in Chronic GVHD

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Hyperbaric Oxygen Brain Injury Treatment Trial

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

MB-105 in Patients With CD5 Positive T-cell Lymphoma

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis